CO MPJE cheat sheet

Missouri pharmacy licensure is administered by the Missouri Board of Pharmacy under the Division of Professional Registration; a Missouri pharmacist license is required to practice, and a separate Missouri controlled substance registration is not issued by the Board (Missouri relies on federal DEA registration plus state licensure).

Pharmacist licensure requires graduation from an ACPE-accredited (or Board-recognized) college of pharmacy, passage of NAPLEX, passage of the Missouri jurisprudence exam (MPJE), and completion of the required internship hours documented on Board forms.

License renewal in Missouri is biennial, expiring October 31 of odd-numbered years; pharmacists must complete 30 contact hours of continuing education per renewal cycle, including at least 2 hours on medication errors and at least 2 hours on pharmacy law (verify current hour breakdown with the Board).

Pharmacy technician registration in Missouri requires application to the Board, and technicians work under the direct supervision of a licensed pharmacist; the pharmacist-to-technician ratio and technician duties are set by Board rule and statute.

A pharmacy license (permit) is site-specific: each physical location must hold its own Missouri pharmacy license, and a change of address, ownership, or pharmacist-in-charge triggers notification or reapplication requirements.

Nonresident pharmacies that dispense to Missouri patients must obtain a Missouri nonresident pharmacy license/registration and comply with Missouri labeling and recordkeeping rules in addition to their home-state requirements.

Continuing education must be ACPE-accredited or Board-approved; licensees must retain CE certificates for a period set by the Board and produce them on audit.

License discipline in other states must be reported to the Missouri Board; failure to report an adverse action is itself grounds for discipline.

Pharmacists may administer vaccines to patients per protocol or prescription; Missouri law authorizes pharmacist vaccination of adults and, under specified conditions, of younger patients, with documentation and reporting requirements.

Collaborative practice arrangements (including consult agreements) allow a pharmacist to modify or manage drug therapy under a written protocol with a prescriber; the agreement must define scope, drugs, and communication requirements.

Pharmacists may dispense and, where authorized, prescribe certain self-administered hormonal contraceptives and other categories defined by statute; the specific drug classes and age limits are set by Missouri law and Board rule.

Emergency contraception and naloxone may be dispensed under standing order/protocol authority; the pharmacist must follow the specific protocol and provide required counseling.

Pharmacists may substitute therapeutically equivalent generic drugs unless the prescriber indicates 'dispense as written' or the patient refuses substitution; the patient must be informed of the substitution right.

Compounding is governed by USP standards adopted by the Board (USP <795> nonsterile, <797> sterile, <800> hazardous drugs); a prescription or a documented patient-specific need is required for compounding.

Pharmacists must perform a prospective drug utilization review (DUR) before dispensing, screening for therapeutic duplication, drug-disease contraindication, drug-drug interaction, incorrect dose, and abuse/misuse.

Pharmacists have authority to refuse to fill a prescription they believe is fraudulent, forged, or not issued for a legitimate medical purpose, and must document the reason.

A valid prescription must contain the patient name, drug name/strength/quantity, directions, prescriber name and address, date issued, and, for controlled substances, the prescriber's DEA number.

Prescriptions may be transmitted orally (except Schedule II, which requires a written, electronic, or emergency oral order under federal rules), by fax, or electronically; electronic prescriptions for controlled substances require DEA-compliant EPCS systems.

Prescription records must be retained for at least 2 years in Missouri (verify current statute/rule); controlled substance records must be kept for 2 years under federal law and be readily retrievable.

Refills: Schedule II prescriptions may not be refilled; Schedule III–IV may be refilled up to 5 times within 6 months of issue; Schedule V refills follow state law and prescription directions.

Partial fills of Schedule II are permitted under federal rules (e.g., remaining quantity within 72 hours, or for LTCF/terminally ill patients up to 60 days), and the pharmacist must document the partial quantity and date.

Prescription transfers between pharmacies must be documented with the transferring and receiving pharmacist names, date, drug, quantity, and refills remaining; controlled substance transfers are limited (Schedule III–V, one-time for refills, EPCS rules apply).

The prescription label must include the pharmacy name and address, prescription number, date, patient name, directions, prescriber name, drug name/strength, quantity, and required auxiliary/cautionary statements.

Prescription files must be readily retrievable and organized so that any prescription can be produced on request by the Board or DEA within the required timeframe.

Controlled substances are classified under the federal CSA into Schedules I–V; Schedule I has no accepted medical use, Schedule II has high abuse potential with accepted medical use, and Schedules III–V have decreasing abuse potential.

A DEA registration is required to handle controlled substances; registrations are site-specific, must be renewed every 3 years, and separate registrations are needed for each location and for dispensing vs. distributing activities.

Schedule II prescriptions must be written, electronically prescribed via EPCS, or (in an emergency) orally transmitted with a written follow-up within 7 days; they may not be refilled.

Schedule III–V prescriptions may be refilled up to 5 times within 6 months; Schedule V may be dispensed without a prescription only where state law permits and with required recordkeeping.

The pharmacist must verify the prescriber's DEA number and legitimate medical purpose; a corresponding responsibility exists to resolve red flags (e.g., pattern prescribing, early refills, out-of-area prescribers) before dispensing.

Controlled substance inventory: a biennial inventory is required (every 2 years), plus an initial inventory when first registering; records of receipt and disposal must be maintained and reconciled.

Theft or significant loss of controlled substances must be reported to DEA in writing within one business day of discovery (DEA Form 106), and to the state Board as required.

CSOS/EPCS rules require identity proofing, two-factor authentication, and audit trails; paper prescriptions for Schedule II must be manually signed and dated by the prescriber.

Pharmacists must offer patient counseling on new and refill prescriptions (unless the patient refuses), covering drug name, purpose, directions, common side effects, interactions, and storage.

Counseling may be provided by a pharmacist or a qualified pharmacy intern/technician under pharmacist supervision, but the pharmacist retains responsibility for the counseling content.

The prescription label must include the pharmacy name/address/phone, prescription number, date filled, patient name, prescriber name, drug name/strength, directions, quantity, and refill information.

Auxiliary labels (e.g., 'may cause drowsiness', 'take with food', 'avoid alcohol') must be applied when the drug requires them; child-resistant packaging is required unless the patient requests otherwise.

Medication guides and patient package inserts must be provided for drugs subject to FDA requirements (e.g., certain antidepressants, NSAIDs, anticoagulants) at dispensing.

Pharmacists must report medication errors and adverse drug events through internal incident reporting and, where required, to external programs (e.g., ISMP, FDA MedWatch).

Patient safety practices include independent double-checks for high-alert medications, look-alike/sound-alike drug separation, and barcode verification at dispensing.

Pharmacists must maintain patient confidentiality under HIPAA and Missouri law, and must provide the Notice of Privacy Practices at the appropriate time.

Every Missouri pharmacy must have a pharmacist-in-charge (PIC) who is responsible for compliance with pharmacy laws, recordkeeping, and supervision of personnel.

The pharmacy must have a designated area for prescription dispensing that is secure and not accessible to the public; the prescription department must be enclosed and lockable.

Pharmacist-to-technician ratios and supervision requirements are set by Missouri statute/rule; technicians may perform only delegated tasks under direct pharmacist supervision.

The pharmacy must maintain a current policy and procedure manual, including protocols for compounding, controlled substances, and emergency procedures.

Facility requirements include adequate lighting, temperature control for drug storage, a sink for compounding, and secure storage for controlled substances.

Personnel records, including licensure verification and training documentation, must be maintained and available for Board inspection.

The pharmacy must post required notices (e.g., license, complaint procedures) and maintain a current license displayed in a conspicuous location.

Continuous quality improvement (CQI) programs are required to track and analyze medication errors and implement corrective actions.

Grounds for discipline include fraud, deception, gross negligence, incompetence, violation of pharmacy laws, and impairment by alcohol or drugs.

The Missouri Board may impose sanctions including reprimand, probation, suspension, revocation, and civil penalties; the licensee has rights to notice and a hearing.

Mandatory reporting: pharmacists must report known violations of the pharmacy practice act, including impaired colleagues and fraudulent prescriptions, to the Board.

The Board conducts inspections and investigations; failure to cooperate with an investigation is itself a disciplinary violation.

Ethical obligations include maintaining patient confidentiality, avoiding conflicts of interest, and providing care regardless of patient characteristics.

Diversion of controlled substances is a criminal offense and a disciplinary matter; pharmacies must have systems to detect and prevent diversion.

Continuing education and remediation may be required as a condition of probation or reinstatement after discipline.

Licensees must respond truthfully and completely to Board inquiries and must not misrepresent credentials or qualifications.

Missouri pharmacist license renewal is biennial (October 31 of odd years); CE requirement is 30 hours per cycle, including at least 2 hours on medication errors and 2 hours on pharmacy law (confirm current Board rule).

Pharmacy technician registration requires Board application; technicians practice under direct pharmacist supervision and must meet ratio limits set by rule.

Each pharmacy location requires a separate Missouri pharmacy license; changes in ownership, address, or PIC require Board notification or reapplication.

Nonresident pharmacies dispensing to Missouri patients need a Missouri nonresident pharmacy license and must follow Missouri labeling and record rules.

CE must be ACPE-accredited or Board-approved; certificates must be retained and produced on audit.

Adverse license actions in other states must be reported to the Missouri Board; failure to report is a separate violation.

Pharmacists may administer vaccines under protocol or prescription, with documentation and reporting to the state immunization registry as required.

Collaborative practice/consult agreements allow pharmacists to modify drug therapy under a written protocol with a prescriber, defining scope and communication.

Pharmacists may dispense self-administered hormonal contraceptives and naloxone under standing order/protocol authority as defined by Missouri law.

Generic substitution is permitted unless the prescriber indicates 'dispense as written' or the patient refuses; the patient must be informed of the substitution right.

Compounding must follow USP <795>/<797>/<800> standards adopted by the Board and requires a prescription or documented patient-specific need.

A prospective DUR is required before dispensing, screening for duplication, interactions, contraindications, incorrect dose, and misuse.

Pharmacists may refuse to fill a prescription they believe is fraudulent or not for a legitimate medical purpose, documenting the reason.

A valid prescription requires patient name, drug/strength/quantity, directions, prescriber name/address, date, and DEA number for controlled substances.

Schedule II prescriptions must be written, EPCS, or emergency oral with written follow-up within 7 days; they may not be refilled.

Schedule III–IV may be refilled up to 5 times within 6 months; Schedule V refills follow state law and prescription directions.

Partial fills of Schedule II are allowed under federal rules (e.g., remainder within 72 hours; LTCF/terminally ill up to 60 days) with documentation.

Prescription transfers must document transferring/receiving pharmacist names, date, drug, quantity, and refills remaining; controlled substance transfers are limited.

Labels must include pharmacy name/address, Rx number, date, patient name, directions, prescriber, drug/strength, quantity, and required auxiliary statements.

Prescription records must be readily retrievable and retained for at least 2 years (verify current Missouri rule).

DEA registration is site-specific and renewed every 3 years; separate registrations are needed per location and activity (dispensing vs. distributing).

Schedule II has high abuse potential with accepted medical use and no refills; Schedule I has no accepted medical use.

Schedule III–V may be refilled up to 5 times within 6 months; Schedule V may be dispensed without a prescription only where state law permits.

Pharmacists have corresponding responsibility to resolve red flags (pattern prescribing, early refills, out-of-area prescribers) before dispensing.

A biennial controlled substance inventory is required, plus an initial inventory at registration; receipts and disposals must be reconciled.

Theft or significant loss must be reported to DEA on Form 106 within one business day of discovery, and to the state Board as required.

EPCS requires identity proofing, two-factor authentication, and audit trails; paper Schedule II prescriptions must be manually signed and dated.

Pharmacists must offer counseling on new and refill prescriptions (unless refused), covering name, purpose, directions, side effects, interactions, and storage.

Counseling may be delivered by a pharmacist or supervised intern/technician, but the pharmacist retains responsibility for content.

Labels must include pharmacy name/address/phone, Rx number, date, patient name, prescriber, drug/strength, directions, quantity, and refills.

Auxiliary labels and child-resistant packaging are required unless the patient requests otherwise; medication guides must be provided when FDA-required.

Medication errors and adverse events must be reported through internal incident systems and, where required, to ISMP or FDA MedWatch.

High-alert medications require independent double-checks; look-alike/sound-alike drugs must be separated and barcode verification used at dispensing.

Patient confidentiality must be maintained under HIPAA and Missouri law, with the Notice of Privacy Practices provided.

Every pharmacy must have a pharmacist-in-charge responsible for legal compliance, recordkeeping, and supervision of personnel.

The prescription department must be enclosed, secure, and not accessible to the public; controlled substances must be securely stored.

Pharmacist-to-technician ratios and supervision requirements are set by Missouri statute/rule; technicians perform only delegated tasks.

A current policy and procedure manual covering compounding, controlled substances, and emergencies must be maintained.

Facility requirements include adequate lighting, temperature control, a compounding sink, and secure storage.

Personnel licensure verification and training records must be maintained and available for Board inspection.

The pharmacy license must be displayed conspicuously, and required notices (e.g., complaint procedures) must be posted.

Grounds for discipline include fraud, gross negligence, incompetence, legal violations, and impairment by alcohol or drugs.

Sanctions include reprimand, probation, suspension, revocation, and civil penalties; licensees have notice and hearing rights.

Pharmacists must report known violations of the pharmacy practice act, including impaired colleagues and fraudulent prescriptions, to the Board.

Failure to cooperate with a Board investigation is itself a disciplinary violation.

Ethical duties include confidentiality, avoiding conflicts of interest, and providing care without discrimination.

Diversion of controlled substances is both a crime and a disciplinary matter; pharmacies must have diversion-detection systems.

Licensees must respond truthfully to Board inquiries and must not misrepresent credentials.

Missouri pharmacist licensure requires an ACPE-accredited degree, NAPLEX, MPJE, and documented internship hours.

Renewal is biennial, expiring October 31 of odd years, with 30 CE hours per cycle including medication error and law hours (verify current rule).

Each pharmacy location needs its own Missouri license; ownership, address, or PIC changes trigger notification or reapplication.

Nonresident pharmacies dispensing to Missouri patients need a Missouri nonresident license and must follow Missouri labeling/record rules.

Technician registration requires Board application; technicians work under direct pharmacist supervision within ratio limits.

Adverse actions in other states must be reported to the Missouri Board; failure to report is a violation.

Pharmacists may administer vaccines under protocol/prescription with documentation and registry reporting.

Collaborative practice agreements allow drug therapy modification under a written prescriber protocol defining scope and communication.

Pharmacists may dispense hormonal contraceptives and naloxone under standing order/protocol authority per Missouri law.

Generic substitution is allowed unless 'dispense as written' is indicated or the patient refuses; patients must be informed of the right to substitute.

Compounding must follow USP <795>/<797>/<800> and requires a prescription or documented patient-specific need.

A prospective DUR is required before dispensing, screening duplication, interactions, contraindications, dosing, and misuse.

Pharmacists may refuse fraudulent or illegitimate prescriptions, documenting the reason.

A valid prescription requires patient name, drug/strength/quantity, directions, prescriber name/address, date, and DEA number for controlled substances.

Schedule II prescriptions must be written, EPCS, or emergency oral with written follow-up within 7 days; no refills.

Schedule III–IV refills are limited to 5 within 6 months; Schedule V refills follow state law and prescription directions.

Partial fills of Schedule II are allowed under federal rules (remainder within 72 hours; LTCF/terminally ill up to 60 days) with documentation.

Transfers must document pharmacist names, date, drug, quantity, and refills remaining; controlled substance transfers are restricted.

Labels must include pharmacy name/address, Rx number, date, patient name, directions, prescriber, drug/strength, quantity, and auxiliary statements.

Prescription records must be readily retrievable and retained at least 2 years (verify current Missouri rule).

DEA registration is site-specific, renewed every 3 years, and separate for each location and activity (dispensing vs. distributing).

Schedule II has high abuse potential with accepted medical use and no refills; Schedule I has no accepted medical use.

Schedule III–V may be refilled up to 5 times within 6 months; Schedule V may be dispensed without a prescription only where state law permits.

Corresponding responsibility requires resolving red flags (pattern prescribing, early refills, out-of-area prescribers) before dispensing.

A biennial inventory is required plus an initial inventory at registration; receipts and disposals must be reconciled.

Theft or significant loss must be reported to DEA on Form 106 within one business day of discovery and to the state Board as required.

EPCS requires identity proofing, two-factor authentication, and audit trails; paper Schedule II prescriptions must be manually signed and dated.

Pharmacists must offer counseling on new and refill prescriptions (unless refused), covering name, purpose, directions, side effects, interactions, and storage.

Counseling may be provided by a pharmacist or supervised intern/technician, but the pharmacist retains responsibility for content.

Labels must include pharmacy name/address/phone, Rx number, date, patient name, prescriber, drug/strength, directions, quantity, and refills.

Auxiliary labels and child-resistant packaging are required unless the patient requests otherwise; medication guides must be provided when FDA-required.

Medication errors and adverse events must be reported through internal systems and, where required, to ISMP or FDA MedWatch.

High-alert medications require independent double-checks; look-alike/sound-alike drugs must be separated and barcode verification used at dispensing.

Patient confidentiality must be maintained under HIPAA and Missouri law, with the Notice of Privacy Practices provided.

Every pharmacy must have a pharmacist-in-charge responsible for legal compliance, recordkeeping, and supervision.

The prescription department must be enclosed, secure, and not accessible to the public; controlled substances must be securely stored.

Pharmacist-to-technician ratios and supervision requirements are set by Missouri statute/rule; technicians perform only delegated tasks.

A current policy and procedure manual covering compounding, controlled substances, and emergencies must be maintained.

Facility requirements include adequate lighting, temperature control, a compounding sink, and secure storage.

Personnel licensure verification and training records must be maintained and available for Board inspection.

The pharmacy license must be displayed conspicuously, and required notices (e.g., complaint procedures) must be posted.

Grounds for discipline include fraud, gross negligence, incompetence, legal violations, and impairment by alcohol or drugs.

Sanctions include reprimand, probation, suspension, revocation, and civil penalties; licensees have notice and hearing rights.

Pharmacists must report known violations of the pharmacy practice act, including impaired colleagues and fraudulent prescriptions, to the Board.

Failure to cooperate with a Board investigation is itself a disciplinary violation.

Ethical duties include confidentiality, avoiding conflicts of interest, and providing care without discrimination.

Diversion of controlled substances is both a crime and a disciplinary matter; pharmacies must have diversion-detection systems.

Licensees must respond truthfully to Board inquiries and must not misrepresent credentials.

Missouri pharmacist licensure requires an ACPE-accredited degree, NAPLEX, MPJE, and documented internship hours.

Renewal is biennial, expiring October 31 of odd years, with 30 CE hours per cycle including medication error and law hours (verify current rule).

Each pharmacy location needs its own Missouri license; ownership, address, or PIC changes trigger notification or reapplication.

Nonresident pharmacies dispensing to Missouri patients need a Missouri nonresident license and must follow Missouri labeling/record rules.

Technician registration requires Board application; technicians work under direct pharmacist supervision within ratio limits.

Adverse actions in other states must be reported to the Missouri Board; failure to report is a violation.

Pharmacists may administer vaccines under protocol/prescription with documentation and registry reporting.

Collaborative practice agreements allow drug therapy modification under a written prescriber protocol defining scope and communication.

Pharmacists may dispense hormonal contraceptives and naloxone under standing order/protocol authority per Missouri law.

Generic substitution is allowed unless 'dispense as written' is indicated or the patient refuses; patients must be informed of the right to substitute.

Compounding must follow USP <795>/<797>/<800> and requires a prescription or documented patient-specific need.

A prospective DUR is required before dispensing, screening duplication, interactions, contraindications, dosing, and misuse.

Pharmacists may refuse fraudulent or illegitimate prescriptions, documenting the reason.

A valid prescription requires patient name, drug/strength/quantity, directions, prescriber name/address, date, and DEA number for controlled substances.

Schedule II prescriptions must be written, EPCS, or emergency oral with written follow-up within 7 days; no refills.

Schedule III–IV refills are limited to 5 within 6 months; Schedule V refills follow state law and prescription directions.

Partial fills of Schedule II are allowed under federal rules (remainder within 72 hours; LTCF/terminally ill up to 60 days) with documentation.

Transfers must document pharmacist names, date, drug, quantity, and refills remaining; controlled substance transfers are restricted.

Labels must include pharmacy name/address, Rx number, date, patient name, directions, prescriber, drug/strength, quantity, and auxiliary statements.

Prescription records must be readily retrievable and retained at least 2 years (verify current Missouri rule).

DEA registration is site-specific, renewed every 3 years, and separate for each location and activity (dispensing vs. distributing).

Schedule II has high abuse potential with accepted medical use and no refills; Schedule I has no accepted medical use.

Schedule III–V may be refilled up to 5 times within 6 months; Schedule V may be dispensed without a prescription only where state law permits.

Corresponding responsibility requires resolving red flags (pattern prescribing, early refills, out-of-area prescribers) before dispensing.

A biennial inventory is required plus an initial inventory at registration; receipts and disposals must be reconciled.

Theft or significant loss must be reported to DEA on Form 106 within one business day of discovery and to the state Board as required.

EPCS requires identity proofing, two-factor authentication, and audit trails; paper Schedule II prescriptions must be manually signed and dated.

Pharmacists must offer counseling on new and refill prescriptions (unless refused), covering name, purpose, directions, side effects, interactions, and storage.

Counseling may be provided by a pharmacist or supervised intern/technician, but the pharmacist retains responsibility for content.

Labels must include pharmacy name/address/phone, Rx number, date, patient name, prescriber, drug/strength, directions, quantity, and refills.

Auxiliary labels and child-resistant packaging are required unless the patient requests otherwise; medication guides must be provided when FDA-required.

Medication errors and adverse events must be reported through internal systems and, where required, to ISMP or FDA MedWatch.

High-alert medications require independent double-checks; look-alike/sound-alike drugs must be separated and barcode verification used at dispensing.

Patient confidentiality must be maintained under HIPAA and Missouri law, with the Notice of Privacy Practices provided.

Every pharmacy must have a pharmacist-in-charge responsible for legal compliance, recordkeeping, and supervision.

The prescription department must be enclosed, secure, and not accessible to the public; controlled substances must be securely stored.

Pharmacist-to-technician ratios and supervision requirements are set by Missouri statute/rule; technicians perform only delegated tasks.

A current policy and procedure manual covering compounding, controlled substances, and emergencies must be maintained.

Facility requirements include adequate lighting, temperature control, a compounding sink, and secure storage.

Personnel licensure verification and training records must be maintained and available for Board inspection.

The pharmacy license must be displayed conspicuously, and required notices (e.g., complaint procedures) must be posted.

Grounds for discipline include fraud, gross negligence, incompetence, legal violations, and impairment by alcohol or drugs.

Sanctions include reprimand, probation, suspension, revocation, and civil penalties; licensees have notice and hearing rights.

Pharmacists must report known violations of the pharmacy practice act, including impaired colleagues and fraudulent prescriptions, to the Board.

Failure to cooperate with a Board investigation is itself a disciplinary violation.

Ethical duties include confidentiality, avoiding conflicts of interest, and providing care without discrimination.

Diversion of controlled substances is both a crime and a disciplinary matter; pharmacies must have diversion-detection systems.

Licensees must respond truthfully to Board inquiries and must not misrepresent credentials.

Missouri pharmacist licensure requires an ACPE-accredited degree, NAPLEX, MPJE, and documented internship hours.

Renewal is biennial, expiring October 31 of odd years, with 30 CE hours per cycle including medication error and law hours (verify current rule).

Each pharmacy location needs its own Missouri license; ownership, address, or PIC changes trigger notification or reapplication.

Nonresident pharmacies dispensing to Missouri patients need a Missouri nonresident license and must follow Missouri labeling/record rules.

Technician registration requires Board application; technicians work under direct pharmacist supervision within ratio limits.

Adverse actions in other states must be reported to the Missouri Board; failure to report is a violation.

Pharmacists may administer vaccines under protocol/prescription with documentation and registry reporting.

Collaborative practice agreements allow drug therapy modification under a written prescriber protocol defining scope and communication.

Pharmacists may dispense hormonal contraceptives and naloxone under standing order/protocol authority per Missouri law.

Generic substitution is allowed unless 'dispense as written' is indicated or the patient refuses; patients must be informed of the right to substitute.

Compounding must follow USP <795>/<797>/<800> and requires a prescription or documented patient-specific need.

A prospective DUR is required before dispensing, screening duplication, interactions, contraindications, dosing, and misuse.

Pharmacists may refuse fraudulent or illegitimate prescriptions, documenting the reason.

A valid prescription requires patient name, drug/strength/quantity, directions, prescriber name/address, date, and DEA number for controlled substances.

Schedule II prescriptions must be written, EPCS, or emergency oral with written follow-up within 7 days; no refills.

Schedule III–IV refills are limited to 5 within 6 months; Schedule V refills follow state law and prescription directions.

Partial fills of Schedule II are allowed under federal rules (remainder within 72 hours; LTCF/terminally ill up to 60 days) with documentation.

Transfers must document pharmacist names, date, drug, quantity, and refills remaining; controlled substance transfers are restricted.

Labels must include pharmacy name/address, Rx number, date, patient name, directions, prescriber, drug/strength, quantity, and auxiliary statements.

Prescription records must be readily retrievable and retained at least 2 years (verify current Missouri rule).

DEA registration is site-specific, renewed every 3 years, and separate for each location and activity (dispensing vs. distributing).

Schedule II has high abuse potential with accepted medical use and no refills; Schedule I has no accepted medical use.

Schedule III–V may be refilled up to 5 times within 6 months; Schedule V may be dispensed without a prescription only where state law permits.

Corresponding responsibility requires resolving red flags (pattern prescribing, early refills, out-of-area prescribers) before dispensing.

A biennial inventory is required plus an initial inventory at registration; receipts and disposals must be reconciled.

Theft or significant loss must be reported to DEA on Form 106 within one business day of discovery and to the state Board as required.

EPCS requires identity proofing, two-factor authentication, and audit trails; paper Schedule II prescriptions must be manually signed and dated.

Pharmacists must offer counseling on new and refill prescriptions (unless refused), covering name, purpose, directions, side effects, interactions, and storage.

Counseling may be provided by a pharmacist or supervised intern/technician, but the pharmacist retains responsibility for content.

Labels must include pharmacy name/address/phone, Rx number, date, patient name, prescriber, drug/strength, directions, quantity, and refills.

Auxiliary labels and child-resistant packaging are required unless the patient requests otherwise; medication guides must be provided when FDA-required.

Medication errors and adverse events must be reported through internal systems and, where required, to ISMP or FDA MedWatch.

High-alert medications require independent double-checks; look-alike/sound-alike drugs must be separated and barcode verification used at dispensing.

Patient confidentiality must be maintained under HIPAA and Missouri law, with the Notice of Privacy Practices provided.

Every pharmacy must have a pharmacist-in-charge responsible for legal compliance, recordkeeping, and supervision.

The prescription department must be enclosed, secure, and not accessible to the public; controlled substances must be securely stored.

Pharmacist-to-technician ratios and supervision requirements are set by Missouri statute/rule; technicians perform only delegated tasks.

A current policy and procedure manual covering compounding, controlled substances, and emergencies must be maintained.

Facility requirements include adequate lighting, temperature control, a compounding sink, and secure storage.

Personnel licensure verification and training records must be maintained and available for Board inspection.

The pharmacy license must be displayed conspicuously, and required notices (e.g., complaint procedures) must be posted.

Grounds for discipline include fraud, gross negligence, incompetence, legal violations, and impairment by alcohol or drugs.

Sanctions include reprimand, probation, suspension, revocation, and civil penalties; licensees have notice and hearing rights.

Pharmacists must report known violations of the pharmacy practice act, including impaired colleagues and fraudulent prescriptions, to the Board.

Failure to cooperate with a Board investigation is itself a disciplinary violation.

Ethical duties include confidentiality, avoiding conflicts of interest, and providing care without discrimination.

Diversion of controlled substances is both a crime and a disciplinary matter; pharmacies must have diversion-detection systems.

Licensees must respond truthfully to Board inquiries and must not misrepresent credentials.